Intended for healthcare professionals

Editorials

Removal of access to alemtuzumab for patients with aggressive multiple sclerosis

BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f275 (Published 18 January 2013) Cite this as: BMJ 2013;346:f275

See other articles in issue 7892

Article tools

PDF 0 responses

Respond to this article
Print
Alerts & updates
Article alerts
Please note: your email address is provided to the journal, which may use this information for marketing purposes.

Log in or register:

Username *

Password *

Register for alerts

If you have registered for alerts, you should use your registered email address as your username
Citation tools
Download this article to citation manager

Alan J Thompson professor of clinical neurology and neurorehabilitation, Gavin Giovannoni professor of neurology

Thompson A J, Giovannoni G. Removal of access to alemtuzumab for patients with aggressive multiple sclerosis BMJ 2013; 346 :f275 doi:10.1136/bmj.f275

BibTeX (win & mac)Download

EndNote (tagged)Download

EndNote 8 (xml)Download

RefWorks Tagged (win & mac)Download

RIS (win only)Download

MedlarsDownload

Help

If you are unable to import citations, please contact technical support for your product directly (links go to external sites):

EndNote

ProCite

Reference Manager

RefWorks

Zotero
Request permissions

Topics